Real World Evidence Scientific Lead
Core
Lead end-to-end real-world evidence (RWE) strategy and execution for the development of teplizumab in autoimmune type 1 diabetes, partnering with global strategy leads and cross-functional teams.
Role type
Senior Scientific Lead, Real-World Evidence (RWE)
Builds
Real-world studies and evidence generation for drug registration, pre-launch, and peri-launch phases
Domain
Biopharmaceuticals, Immunology, Diabetes, Pharmaco-epidemiology
Required skills
Pharmaco-epidemiology, Health Outcomes Research (HEOR), RWE study design, End-to-end project management, Data analysis, Budget management, Regulatory evidence generation, Cross-functional collaboration, Strategic planning, Methodological expertise
Preferred skills
Business education, Experience in transplant and cardiovascular therapeutic areas, Second European language
Technologies
Routinely collected healthcare data, AI-powered research platforms
Responsibilities
Manage end-to-end planning and execution of RWE studies ensuring high scientific rigor and on-time delivery; Deliver strategic scientific input from study conceptualization through closure including design, cohort construction, and statistical analysis; Identify and validate external fit-for-purpose data sources and institutions; Manage RWE study budgets in collaboration with internal and external stakeholders; Serve as methodological expert in innovative RWE study designs to address evidence gaps; Maintain alignment with stakeholders on evidence strategy and study progress.
Seniority
Senior, hands-on IC with leadership experience
